BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 11857956)

  • 1. [Preparation and evaluation of press-coated aminophylline tablet using crystalline cellulose and polyethylene glycol in the outer shell for timed-release dosage forms].
    Watanabe Y; Mukai B; Kawamura K; Ishikawa T; Namiki M; Utoguchi N; Fujii M
    Yakugaku Zasshi; 2002 Feb; 122(2):157-62. PubMed ID: 11857956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on applicability of press-coated tablets using hydroxypropylcellulose (HPC) in the outer shell for timed-release preparations.
    Fukui E; Uemura K; Kobayashi M
    J Control Release; 2000 Aug; 68(2):215-23. PubMed ID: 10925130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compression forces and amount of outer coating layer affecting the time-controlled disintegration of the compression-coated tablets prepared by direct compression with micronized ethylcellulose.
    Lin KH; Lin SY; Li MJ
    J Pharm Sci; 2001 Dec; 90(12):2005-9. PubMed ID: 11745759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of enteric coated timed-release press-coated tablets and evaluation of their function by in vitro and in vivo tests for colon targeting.
    Fukui E; Miyamura N; Uemura K; Kobayashi M
    Int J Pharm; 2000 Aug; 204(1-2):7-15. PubMed ID: 11011980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets.
    Lin SY; Lin KH; Li MJ
    J Pharm Sci; 2002 Sep; 91(9):2040-6. PubMed ID: 12210050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrophilic excipients modulate the time lag of time-controlled disintegrating press-coated tablets.
    Lin SY; Li MJ; Lin KH
    AAPS PharmSciTech; 2004 Aug; 5(4):e54. PubMed ID: 15760051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro/in-vivo correlation of pulsatile drug release from press-coated tablet formulations: a pharmacoscintigraphic study in the beagle dog.
    Ghimire M; McInnes FJ; Watson DG; Mullen AB; Stevens HN
    Eur J Pharm Biopharm; 2007 Sep; 67(2):515-23. PubMed ID: 17498934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosage form design and in vitro/in vivo evaluation of cevimeline extended-release tablet formulations.
    Tajiri S; Kanamaru T; Kamada M; Konno T; Nakagami H
    Int J Pharm; 2010 Jan; 383(1-2):99-105. PubMed ID: 19747964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time-release compression-coated core tablet containing nifedipine for chronopharmacotherapy.
    Sawada T; Kondo H; Nakashima H; Sako K; Hayashi M
    Int J Pharm; 2004 Aug; 280(1-2):103-11. PubMed ID: 15265551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro dissolution and in vivo gamma scintigraphic evaluation of press-coated salbutamol sulfate tablets.
    Li W; Shi CH; Sheng YL; Cui P; Zhao YQ; Zhang XR
    Acta Pharm; 2013 Dec; 63(4):545-51. PubMed ID: 24451078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissolution of tablet-in-tablet formulations studied with ATR-FTIR spectroscopic imaging.
    Wray PS; Clarke GS; Kazarian SG
    Eur J Pharm Sci; 2013 Mar; 48(4-5):748-57. PubMed ID: 23291036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Release behavior and photo-image of nifedipine tablet coated with high viscosity grade hydroxypropylmethylcellulose: effect of coating conditions.
    Cao QR; Choi HG; Kim DC; Lee BJ
    Int J Pharm; 2004 Apr; 274(1-2):107-17. PubMed ID: 15072787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A controlled porosity osmotic pump system with biphasic release of theophylline.
    Bi Y; Mao S; Gan L; Li Y; Wang C; Xu N; Zheng Y; Cheng Q; Hou S
    Chem Pharm Bull (Tokyo); 2007 Nov; 55(11):1574-80. PubMed ID: 17978514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation design of double-layer in the outer shell of dry-coated tablet to modulate lag time and time-controlled dissolution function: studies on micronized ethylcellulose for dosage form design (VII).
    Lin SY; Lin KH; Li MJ
    AAPS J; 2004 Jul; 6(3):e17. PubMed ID: 15760102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and optimization of colon-targeted system of theophylline for chronotherapy of nocturnal asthma.
    Patel MM; Amin AF
    J Pharm Sci; 2011 May; 100(5):1760-72. PubMed ID: 21154966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of fixed dose combination and physicochemical characterization of enteric-coated bilayer tablet with circadian rhythmic variations containing telmisartan and pravastatin sodium.
    Luo D; Kim JH; Park C; Oh E; Park JB; Cui JH; Cao QR; Lee BJ
    Int J Pharm; 2017 May; 523(1):343-356. PubMed ID: 28330645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo drug release from hydrophilic dextran tablets capable of forming polyion complex.
    Miyazaki Y; Tanaka Y; Yakou S; Takayama K
    J Control Release; 2006 Aug; 114(1):47-52. PubMed ID: 16824636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and evaluation of a dry coated drug delivery system with an impermeable cup, swellable top layer and pulsatile release.
    Efentakis M; Koligliati S; Vlachou M
    Int J Pharm; 2006 Mar; 311(1-2):147-56. PubMed ID: 16436321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel chronotherapeutic rectal aminophylline delivery system for therapy of asthma.
    Shiohira H; Fujii M; Koizumi N; Kondoh M; Watanabe Y
    Int J Pharm; 2009 Sep; 379(1):119-24. PubMed ID: 19555748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Release characteristics and in vitro-in vivo correlation of pulsatile pattern for a pulsatile drug delivery system activated by membrane rupture via osmotic pressure and swelling.
    Lin HL; Lin SY; Lin YK; Ho HO; Lo YW; Sheu MT
    Eur J Pharm Biopharm; 2008 Sep; 70(1):289-301. PubMed ID: 18539015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.